Bio-convertible artificial bone with slow release of anti-osteoporosis drug is useful to treat osteoporosis. Apatite cement containing 6% simvastatin (APD) had lower crystallinity than natural bone. In-vitro drug release tests in simulated body fluid (pH 7.8) and acetate buffer (pH 4.5) were performed at 37.0 C as physical models of osteoblast and osteoclast conditions (SOB and SOC). The device had lower drug release rate under SOB, but significantly higher rates under SOC. The simvastatin release rate changed depending on dissolution media, it repeated twice, and the rate under SOC was 15 times higher than under SOB. The device showed dissolution medium responsive drug release. After implantation of the APD in osteoporosis rats, the bone mineral density was evaluated by the x-ray computed tomography. The result indicated that the bone mineral density of APD implanted rat was significantly higher than that of control diseased. The result indicated that the device was therapeutically useful to bone regeneration.
BaronR, VigneryA, HorowitzM.Lymphocytes, Macrophages and the Regulation of Bone Remodeling in Bone and Mineral Research.Annual 2 (PeckW A., ed), Amsterdam, Elsevier, pp. 209–79 (1987).
AlldredgeBK, KimbleK, AnneM, YoungL, KradjanWA, GuglielmoBJ.Applied therapeutics: the clinical use of drugs.Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. pp. 101–3 (2009).
4.
El-KhouryGY, MooreTE, AlbrightJP, HuangHK, MartinRK.Sodium Fluoride Treatment of Osteoporosis: Radiologic Findings.AJR Am J Roentgenol1982; 139: 39–43.
MeunierPJ, VignotE, GarneroP.Treatment of postmenopausal women with osteoporosis or low bone density with raloxifene.Raloxifene Study Group. Osteoporos Int1999; 10: 330–6.
9.
NicholsonGC, MoseleyJM, SextonPM, MendelsohnFA, MartinTJ.Abundant calcitonin receptors in isolated rat osteoclasts, Biochemical and autoradiographic characterization.Abundant calcitonin receptirs in solated rat osteoclasts. J Clin Invest1986; 78: 355–60.
10.
ReginsterJY, SeemanE, De VernejoulMC.Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: treatment of peripheral osteoporosis (TROPOS) study.J Clin Endocrinol Metab2005; 90: 2816–22.
11.
BlakeGM, FogelmanI.The correction of BMD measurements for bone strontium content.J Clin Densitom2007; 10: 259–65.
12.
TobertJA.New developments in lipid-lowering therapy.The role of inhibitors of hydroxymethylglutaryl-coenzyme A reductase. Circulation1987; 534–8.
13.
MundyG, GarrettR, HarrisS, Stimulation of Bone Formation in Vitro and in Rodents by StatinsScience1999; 3: 1946–9.
14.
OxlundH, DalstraM, AndreassenTT.Statin given perorally to adult rats increases cancellous bone mass and compressive strength.Calcified Tissue Int2001; 69: 299–304.
15.
IzumoN, FujitaT, NakamutaH, KoidaM.Lipophilic statins can be osteogenic by promoting osteoblastic calcification in a Cbfa1- and BMP-2- independent manner.Methods Find Exp Clin Pharmacol2001; 23: 389–94.
16.
MaedaT, MatsunumaA, KurahashiI, YanagawaT, YoshidaH, HoriuchiN.Induction of osteoblast differentiation indices by statins in MC3T3-E1 cells.J Cell Biochem2004; 92: 458–71.
17.
MaedaT, MatsunumaA, KawaneT, HoriuchiN.Simvastatin promotes osteoblast differentiation and mineralization in MC3T3-E1 cells.Biochem Biophys Res Commun2001; 280: 874–7.
18.
MaedaT, KawaneT, HoriuchiN.Statins augment vascular endotherial growth factor expression in osteoblastic cells via inhibition of protein prenylation.Endocrinology2003; 144: 681–92.
19.
AyukawaY, OkamuraA, KoyanoK.Simvastatin promotes osteogenesis around titanium implants.A histological and histometrical study in rats. Clin Oral Implants Res2005; 15: 346–50.
BaekKH, LeeWY, OhKW, The effect of simvastatin on the proliferation and differentiation of human bone marrow stromal cells.J Korean Med Sci2005; 20: 438–44.
22.
TikizC, TikizH, TaneliF, GumuserG, TuzunC.Effects of simvastatin on bone mineral density and remodeling parameters in postmenopausal osteopenic subjects: 1-year follow-up study.Clin Rheumatol2005; 24: 447–52.
23.
ToddPA, GoaK.Simvastatin: a review of its pharmacological properties and therapeutic potential in hypercholesterolaemia.Drugs1990; 40: 583–607.
24.
von StechowD, FishS, YahalomD, Does simvastatin stimulate bone formation in vivo?BMC Musculoskelet Disord2003; 4: 8.
SteinD, LeeY, SchmidMJ, Local simvastatin effects on mandibular bone growth and inflammation.J Periodontol2005; 76: 1861–70.
27.
KokuboT, KushitaniH, SakkaS, KitsugiT, YamamuroT.Solution Able to Reproduce In vivo Surface-Structure Changes in Bioactive Glass-ceramic A-W.J Biomed Mater Res Part A1990; 24: 721–34.
28.
TokudomeY, OtsukaM, ItoA, LeGerosRZ.Long-Term Therapeutic Effect of Novel Calcium Phosphate-based Compounds Injected in Ovariectomized Rats.J Biomed Mat Res Part B Applied Biomaterials2009; 90: 229–37.
29.
OtsukaM, YoneokaK, MatsudaY, FoxJL, HiguchiWI.Effect of Plasma-calcium- level-responsive Oestradiol Release From Apatitic Bone Cement on Bone Mineral Density in Ovariectomized Rats, and Its Physicochemical Mechanism.J Pharm Pharmacol1999; 51: 475–81.
30.
HiguchiT.Mechanism of sustained-action medication.Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci1963; 52: 1145–50.
31.
OtsukaM, MatsudaY, YuD, WongJ, FoxJL, HiguchiWI.A Novel Skeletal Drug Delivery System for Anti-Bacterial Drugs by Using Self-Setting Hydroxyapatite Cement.Chem Pharm Bull1990; 38: 3500–2.
